SCHEMBL3980905

SCHEMBL3980905

CCOC(=O)C1CCN(C(=O)OC(C)(C)C)CC1NC(=O)CC(=O)OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
TSHR P16473 1/20 0.42
EPHX1 P07099 1/20 0.39
MAPT P10636 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
GPR119 Q8TDV5 2/20 0.37
USP30 Q70CQ3 1/20 0.36
PTPN2 P17706 1/20 0.36
PTPN1 P18031 1/20 0.36
PTPN6 P29350 1/20 0.36
LMNA P02545 1/20 0.35
THRB P10828 1/20 0.35
HPGD P15428 2/20 0.35
KDM4E B2RXH2 1/20 0.35
GLA P06280 1/20 0.35
RECQL P46063 1/20 0.35
HSD17B10 Q99714 1/20 0.35
GAA P10253 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14319944 0.88 EPHX1 (0.42) ALDH1A1MEN1KMT2AEPHX1MAPT
SCHEMBL30738868 0.86 MEN1 (0.50) ALDH1A1MEN1KMT2ATSHREPHX1
SCHEMBL16765558 0.83 KMT2A (0.39) ALDH1A1MEN1KMT2ATSHREPHX1
SCHEMBL16765557 0.83 KMT2A (0.39) ALDH1A1MEN1KMT2ATSHREPHX1
SCHEMBL28637510 0.83 KMT2A (0.39) ALDH1A1MEN1KMT2ATSHREPHX1
SCHEMBL3983381 0.82 EPHX1 (0.41) ALDH1A1MEN1KMT2AEPHX1MAPT
SCHEMBL3988956 0.80 PDE4B (0.46) EPHX1USP30
SCHEMBL3988958 0.80 PDE4B (0.46) EPHX1USP30
SCHEMBL17756103 0.80 ALDH1A1 (0.48) ALDH1A1MEN1KMT2ATSHREPHX1
SCHEMBL21682548 0.79 ALDH1A1 (0.45) ALDH1A1MEN1KMT2ATSHREPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090325948-A1 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE HURLEY TIMOTHY BRIAN 2009-12-31 US disclosed
US-20090325948-A1 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE HURLEY TIMOTHY BRIAN 2009-12-31 US disclosed
EP-2059305-A2 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE Novartis Ag (CH) 2009-05-20 EP disclosed
WO-2008014307-A2 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE NOVARTIS AG (CH) 2008-01-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325948-A1 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE FDPS, UMPS, GGPS1 ALDH1A1 3119/4885MEN1 2345/4885KMT2A 4780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.